Other bulletins in this series include:

Breast Surgery

Monday 3 March 2008

Critical Care Medicine

March 2008, Volume 36, Issue 3


Feature Articles
669-675
Anatomical and functional intrapulmonary shunt in acute respiratory distress syndrome
Massimo Cressoni, MD; Pietro Caironi, MD; Federico Polli, MD; Eleonora Carlesso, MSc; Davide Chiumello, MD; et al

676-682
The Stability and Workload Index for Transfer score predicts unplanned intensive care unit patient readmission: Initial development and validation
Ognjen Gajic, MD; Michael Malinchoc, PhD; et al

683-689
Serum thrombomodulin level relates to the clinical course of disseminated intravascular coagulation, multiorgan dysfunction syndrome, and mortality in patients with sepsis
Shu-Min Lin, MD; Yu-Min Wang, MD; Horng-Chyuan Lin, MD; et al
690-696
Temporal changes in management and outcome of septic shock in patients with malignancies in the intensive care unit
Frédéric Pène, MD; Stéphanie Percheron, MD; Virginie Lemiale, MD; et al

Continuing Medical Education Article
697-705
Sleep and recovery from critical illness and injury: A review of theory, current practice, and future directions
Randall S. Friese, MD

706-714
Economic evaluation of propofol and lorazepam for critically ill patients undergoing mechanical ventilation
Christopher E. Cox, MD, MPH; Shelby D. Reed, PhD; Joseph A. Govert, MD; et al
Continuing Medical Education Questions
715
Continuing Medical Education Questions

Clinical Investigations
716-723
Immunoglobulin G treatment of postcardiac surgery patients with score-identified severe systemic inflammatory response syndrome—The ESSICS study
for the Early Supplemental Severe SIRS Treatment With IVIG in Score-Identified High-Risk Patients After Cardiac Surgery (ESSICS) Study Group

724-730
Prolonged acute mechanical ventilation, hospital resource utilization, and mortality in the United States
Marya D. Zilberberg, MD; Rose S. Luippold, MS; Sandra Sulsky, PhD; et al

731-736
Community meetings for emergency research community consultation
Jenice N. Longfield, MD, MPH, COL (Ret), MC, USA; et al
737-744
Randomized trial of combination versus monotherapy for the empiric treatment of suspected ventilator-associated pneumonia
for the Canadian Critical Care Trials Group

745-751
Effects of human atrial natriuretic peptide on renal function in patients undergoing abdominal aortic aneurysm repair
Chieko Mitaka, MD; Toshifumi Kudo, MD; Masatoshi Jibiki, MD; et al
752-758
Contribution of various metabolites to the “unmeasured” anions in critically ill patients with metabolic acidosis
Miriam Moviat, MD; Anniek M. Terpstra, BSc; Wim Ruitenbeek, PhD; et al
759-765
Elevated cardiac troponin is an independent risk factor for short- and long-term mortality in medical intensive care unit patients
Luciano Babuin, MD, PhD; Vlad C. Vasile, MD, PhD; Jose A. Rio Perez, MD; et al
766-774
Isolated and reversible impairment of ventricular relaxation in patients with septic shock
Bélaïd Bouhemad, MD; Armelle Nicolas-Robin, MD; Charlotte Arbelot, MD; et al

775-781
Early prognostic value of the medical emergency team calling criteria in patients admitted to intensive care from the emergency department
Reto Etter, MD; Roger Ludwig, MD; Friedrich Lersch, MD; et al

782-788
A double-blind placebo-controlled study to evaluate the safety and efficacy of L-2-oxothiazolidine-4-carboxylic acid in the treatment of patients with acute respiratory distress syndrome
Peter E. Morris, MD; Peter Papadakos, MD; James A. Russell, MD; et al

789-794
Noninvasive ventilation for acute respiratory failure near the end of life
Tasnim Sinuff, MD, PhD; Deborah J. Cook, MD, MSc; Sean P. Keenan, MD, MSc; et al

795-800
Equimolar doses of mannitol and hypertonic saline in the treatment of increased intracranial pressure
Gilles Francony, MD; Bertrand Fauvage, MD; Dominique Falcon, MD; et al

801-806
Short- and long-term follow-up of intensive care unit patients after sedation with isoflurane and midazolam—A pilot study
Peter V. Sackey, MD, PhD; Claes-Roland Martling, MD, PhD; et al

812-817
Outcomes of patients considered for, but not admitted to, the intensive care unit
Thomas E. Vanhecke, MD; Mihirkumar Gandhi, MD; Peter A. McCullough, MD, MPH, FACC, FACP, FAHA, FCCP; et al

Laboratory Investigations
818-827
Noisy pressure support ventilation: A pilot study on a new assisted ventilation mode in experimental lung injury
Marcelo Gama de Abreu, MD, MSc, PhD, DEAA; Peter M. Spieth, MD; et al

Review Articles
933-940
Educational interventions for prevention of healthcare-associated infection: A systematic review
Nasia Safdar, MD, MS; Cybéle Abad, MD

941-952
Procalcitonin assay in systemic inflammation, infection, and sepsis: Clinical utility and limitations
Kenneth L. Becker, MD, PhD; Richard Snider, PhD; Eric S. Nylen, MD

Special Articles
953-963
Recommendations for end-of-life care in the intensive care unit: A consensus statement by the American Academy of Critical Care Medicine
Robert D. Truog, MD, MA; Margaret L. Campbell, PhD, RN, FAAN; et al

964-966
Sepsis: Time to reconsider the concept
Jean Carlet, MD; Jonathan Cohen, MD; Thierry Calandra, MD, PhD; Steven M. Opal, MD; et al
Brief Reports

967-970
Autonomic dysfunction predicts both 1- and 2-month mortality in middle-aged patients with multiple organ dysfunction syndrome
Hendrik Schmidt, MD; Dirk Hoyer, PhD; Ralf Hennen; Konstantin Heinroth; et al

984-985
Intensive care unit readmission: The issue is safety not frequency
Jack E. Zimmerman, MD, FCCM

987-988
Reevaluating prognosis: Cancer, septic shock, and changing outcomes
Karl W. Thomas, MD

988-989
To sleep in an intensive care unit, perchance to heal
Jonathan E. Kass, MD

990-991
Importance of systems-based practice in achieving pharmacoeconomic benefits
Philip D. Lumb, MB BS, FCCM

993-994
Toward ethical best practices in community consultation for research conducted with waiver of informed consent
Laurence B. McCullough, PhD

994-995
How can earlier antibiotic efficacy be provided for ventilator-associated pneumonia without promoting bacterial resistance? Is initial monotherapy or a combination of antibiotics the right answer?
Laurent Papazian, MD

999-1000
Sepsis-induced left ventricular diastolic dysfunction: Little time to relax
Rubin I. Cohen, MD, FCCM

1001-1002
Finally, a tool for triage?
Carolyn Bekes, MD

1002-1003
Our failure to report failure
James M. O’Brien, Jr, MD, MSc; Scott K. Aberegg, MD, MPH

1003-1004
Noninvasive ventilation for patients near the end of life: What do we know and what do we need to know?
William J. Ehlenbach, MD; J Randall Curtis, MD, MPH

1005-1006
Mannitol and hypertonic saline: Going head to head
Roger Härtl, MD; Matteus Froelich, MD

1006-1007
Memories of the intensive care unit
Peter J. Papadakos, MD, FCCM

1009-1011
When mechanical ventilation mimics nature
Theodoros Vassilakopoulos, MD; Spyros Zakynthinos, MD

1011-1012
Leptin and ghrelin: Through thick and thin
Albertus Beishuizen, MD, PhD; Armand R. J. Girbes, MD, PhD; A B. Johan Groeneveld, MD, PhD, FCCP, FCCM

1012-1014
Resuscitation end points in severe sepsis: Central venous pressure, mean arterial pressure, mixed venous oxygen saturation, and … intra-abdominal pressure
Michael L. Cheatham, MD, FACS, FCCM

1014-1015
Gene expression profiling in acute respiratory distress syndrome: Pathways to future interventions
Richard G. Wunderink, MD

1016-1018
Antithrombotic therapies for cardiac arrest: Have we missed the mark?
Karl B. Kern, MD, FSCAI; Robert A. Berg, MD, FCCM; Mathias Zuercher, MD; Michael Loedl, BS

1024-1025
Measuring preload—One size doesn’t necessarily fit all
Margaret M. Parker, MD, FCCM

1025-1027
Measures of parasympathetic function and risk stratification in critical care
Phyllis K. Stein, PhD

Letter to the Editor
1028
Volume therapy and innate immune response during systemic inflammation or sepsis
Mirrin J. Dorresteijn, MD; Hans G. van der Hoeven, MD, PhD; Peter Pickkers, MD, PhD

1028-1029
Volume therapy and innate immune response during systemic inflammation or sepsis
Emanuel P. Rivers, MD, MPH, IOM

Critical Care Medicine
© 2008 Lippincott Williams & Wilkins, Inc.

No comments: